Samsung Biologics starts operations at world’s largest bio manufacturing plant
CDMO Samsung Biologics has started partial operations at Plant 4 – the world’s largest single bio manufacturing plant – this month.
Archives for October 13, 2022
Merck builds out Asian manufacturing presence with $500m investment
The company will expand its manufacturing hub in Singapore to add the ability to produce biologics and vaccines, alongside other capabilities.
Sanofi makes $20m bet on approval of type 1 diabetes treatment
Sanofi secures first negotiation rights for Provention’s monoclonal antibody to treat type 1 diabetes.
Merck pays $250m to develop and commercialize personalized cancer vaccine with Moderna
Merck has exercised its option to jointly develop and commercialize a personalized cancer vaccine (PVC) with Moderna following 'significant progress' made by the two companies in the field to date.